Cargando…

Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study

BACKGROUND: 5-Fluorouracil (5-FU) and capecitabine-associated cardiotoxicity ranging from asymptomatic electrocardiography (ECG) abnormalities to severe myocardial infarction has been reported in a number of studies, but such cardiotoxicity in Chinese patients with malignant diseases has not been in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jianjun, Dong, Chao, Wang, Chang, Li, Weihua, Yu, Hao, Zhang, Min, Zhao, Qun, Zhu, Bo, Zhang, Jun, Li, Wenliang, Wang, Fenghua, Wu, Qiong, Zhou, Wenhao, Yuan, Ying, Qiu, Meng, Chen, Gong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953402/ https://www.ncbi.nlm.nih.gov/pubmed/29764506 http://dx.doi.org/10.1186/s40880-018-0292-1

Ejemplares similares

Capecitabine-induced cardiotoxicity: case report and review of the literature
por: Ang, C., et al.
Publicado: (2010)

Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise
por: Lestuzzi, Chiara, et al.
Publicado: (2022)

5-fluorouracil and cardiotoxicity: a review
por: Sara, Jaskanwal D., et al.
Publicado: (2018)

5-Fluorouracil Rechallenge After Cardiotoxicity
por: Desai, Aakash, et al.
Publicado: (2020)

Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020)

5-Fluorouracil Cardiotoxicity: Known But Unknown
por: Brell, Joanna M.
Publicado: (2021)

Meta-Analysis of Capecitabine versus 5-Fluorouracil in Advanced Gastric Cancer
por: Wu, Zhongliang, et al.
Publicado: (2023)

Rare Presentation of Cardiotoxicity Related to 5-Fluorouracil
por: Charkviani, Mariam, et al.
Publicado: (2020)

5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms
por: Faheem, Beenish, et al.
Publicado: (2022)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)

A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine
por: Chahin, Michael, et al.
Publicado: (2020)

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
por: Osterlund, P., et al.
Publicado: (2022)

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity
por: Cianci, G, et al.
Publicado: (2003)

Colchicine Ameliorates 5-Fluorouracil-Induced Cardiotoxicity in Rats
por: Safarpour, Soheila, et al.
Publicado: (2022)

Successful capecitabine rechallenge following 5-fluorouracil-induced Takotsubo syndrome
por: Abdelrahman, Mohamed, et al.
Publicado: (2016)

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?
por: Fontanella, Caterina, et al.
Publicado: (2014)

Cost-effectiveness Analysis of Fluorouracil, Leucovorin, and Irinotecan versus Epirubicin, Cisplatin, and Capecitabine in Patients with Advanced Gastric Adenocarcinoma
por: Wen, Feng, et al.
Publicado: (2016)

A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
por: Polk, Anne, et al.
Publicado: (2014)

Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Alliot, C
Publicado: (2006)

Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
por: Koukourakis, Georgios V., et al.
Publicado: (2008)

Assessing the risks of capecitabine and its active metabolite 5-fluorouracil to freshwater biota
por: Venâncio, Cátia, et al.
Publicado: (2023)

Rechallenge capecitabine after fluoropyrimidine-induced cardiotoxicity in rectal cancer: A case report
por: Peng, Tao, et al.
Publicado: (2019)

Safety and efficacy of combining capecitabine and temozolomide (CAPTEM) to treat advanced neuroendocrine neoplasms: A meta-analysis
por: Lu, Yaoheng, et al.
Publicado: (2018)

Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer: A meta-analysis
por: Zhu, Jinfeng, et al.
Publicado: (2019)

Co-delivery of Cisplatin(IV) and Capecitabine as an Effective and Non-toxic Cancer Treatment
por: Xiao, Xiao, et al.
Publicado: (2019)

Reply: Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2006)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

An Oral Fluorouracil Prodrug, Capecitabine, Mitigates a Gram-Positive Systemic Infection in Mice
por: McLeod, Jack R., et al.
Publicado: (2021)

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
por: Zhang, Minmin, et al.
Publicado: (2016)

Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
por: Dong, Si-Qi, et al.
Publicado: (2021)

Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity
por: Ma, Wen Wee, et al.
Publicado: (2016)

Cardiotoxicity of commercial 5-fluorouracil vials stems from the alkaline hydrolysis of this drug.
por: Lemaire, L., et al.
Publicado: (1992)

5-Fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report
por: McGlinchey, Paul G, et al.
Publicado: (2001)

Protective Effect of Kaempferol and Its Nanoparticles on 5-Fluorouracil-Induced Cardiotoxicity in Rats
por: Safarpour, Soheila, et al.
Publicado: (2022)

Reintroduction of 5-Fluorouracil Post-cardiac Arrest Secondary to Chemotherapy-Induced Cardiotoxicity
por: Wu, Kathie, et al.
Publicado: (2023)

The Impact of Metformin on the Development of Hypothyroidism and Cardiotoxicity Induced by Cyclophosphamide, Methotrexate, and Fluorouracil in Rats
por: Alhowail, Ahmad H., et al.
Publicado: (2023)

Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study
por: Mahmood, Reem D., et al.
Publicado: (2021)

Indole Alkaloid Derivative B, a Novel Bifunctional Agent That Mitigates 5-Fluorouracil-Induced Cardiotoxicity
por: Bi, Wei, et al.
Publicado: (2018)

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2005)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: A Comparison of Bolus 5-Fluorouracil/Leucovorin and Capecitabine
por: Yoney, Adnan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_28j34grfhr3ic00s1gta51oof3